Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to include the finalized citation for the phase 2b INCEPTION study on Tezepelumab, reflecting a new publication date and revision number. Additionally, a previous note about the modernization of ClinicalTrials.gov data ingest has been removed.SummaryDifference0.8%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.7%
- Check69 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check83 days agoChange DetectedThe page has been updated to include new publications related to the treatment of chronic spontaneous urticaria, specifically highlighting the results of the phase 2b INCEPTION study. Additionally, the revision number has been updated to v2.15.0, indicating a new version of the content.SummaryDifference16%
Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.